<DOC>
	<DOC>NCT00736151</DOC>
	<brief_summary>The purpose of this study is to examine the effects of various increasing doses of Ralfinamide in patients with neuropathic pain.</brief_summary>
	<brief_title>Phase II Dose Titration Study in Patients With Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Male or female patients Females postmenopausal for at least 12 months, 24 months in India, Poland, and Austria Diagnosed by neurologist with current neuropathic pain See inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>